CombiGene AB

One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 7.50.

Update (12.10.2015): Today marks the start of the first subscription period for TO 1.

Update (08.02.2016): Today marks the start of the last subscription period for TO 1.

One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for price correspondning to seventy (70) percent volume-weighted average trading price at Nasdaq First North Sweden marketplace from the period of August 15, 2019 until August 28, 2019 but at least SEK 2.0 per share up to the maximum of SEK 2.50 per share. The subscription period with the support of warrants will take place from September 1, 2019 until September 30, 2019.

Update (24.10.2018): Information about CombiGene's warrant.

One (1) warrant of series TO 3 entitles the holder to subscribe for one (1) new share in the Company for the subscription price which will be determined with the guidance of ten (10) trading days volume-weighted average price (VWAP) before the redemption with a discount of thirty (30) percent, but at least SEK 0.4 per share and a maximum of SEK 0.6 per share.

Update (17.08.2020): Exercise period for warrants of series TO3 in CombiGene begins today.

One (1) warrant of series TO 4 entitles the holder to subscribe for one (1) new share in the Company for the subscription price which will be determined with the guidance of ten (10) trading days volume-weighted average price (VWAP) before the redemption with a discount of thirty (30) percent, but at least SEK 0.5 per share and a maximum of SEK 0.7 per share.

Update (16.11.2020): Exercise period for warrants of series TO4 and TO5 in CombiGene AB begins today.